Differentiation of herpes simplex virus-induced fusion from without and fusion from within by cyclosporin A and compound 48/80

References

1. Bond V. C., Person S. 1984; Fine structure physical map locations of alterations that affect cell fusion in herpes simplex virus type 1. Virology 132:368–376
   [Google Scholar]
2. Epand R. M., Epand R. F., McKenzie R. C. 1987; Effects of viral chemotherapeutic agents in membrane properties. Studies on cyclosporin A, benzyloxy carbonyl-d-Phe-l-Phe-Gly and amantadine. Journal of Biological Chemistry 262:1526–1529
   [Google Scholar]
3. Falke D., Kahl G. F. 1971; The inhibitory effect of compound 48/80 on the formation of giant cells induced by herpesvirus hominis. Journal of General Virology 10:273–277
   [Google Scholar]
4. Falke D., Netter K. J. 1969; Die Hemmung der Riesenzellbildung durch das sogenannte compound 48/80 nach der Infektion mit dem Herpes hominis. I. Die Wirkung auf die Virussynthese. Archiv für die gesamte Virusforschung 28:308–324
   [Google Scholar]
5. Falke D., Knoblich A., Müller S. 1985; Fusion from without induced by herpes simplex virus type 1. Intervirology 24:211–219
   [Google Scholar]
6. Handschumacher R. E., Harding M. W., Rice J., Drugge R. J., Speicher D. W. 1984; Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544–547
   [Google Scholar]
7. Heeg U., Dienes H. P., Müller S., Falke D. 1986; Involvement of actin-containing microfilaments in HSV-induced cytopathology and the influence of inhibitors of glycosylation. Archives of Virology 91:257–270
   [Google Scholar]
8. Hess A. D., Colombani P. M. 1986; Mechanism of action of cyclosporin: role of calmodulin, cyclophilin and other cyclosporinbinding proteins. Transplantation Proceedings 18: supplement 5219–237
   [Google Scholar]
9. Just I., Falke D. 1974; Inhibition of giant cell formation by compound 48/80 after infection with herpes virus hominis. IV. Compound 48/80, an inhibitor of choline-kinase activity. Archives of Virology 46:140–147
   [Google Scholar]
10. LeGrue S. J., Friedman A. W., Kahan B. D. 1983; Lack of evidence for a cyclosporin receptor on human lymphocyte membranes. Transplantation Proceedings 15: supplement 12259–2264
    [Google Scholar]
11. Little P. S., Schaffer P. A. 1981; Expression of the syncytial (syn) phenotype in HSV-1, strain KOS: genetic and phenotypic studies of mutants in two syn loci. Virology 112:686–702
    [Google Scholar]
12. McKenzie R. C., Epand R. M., Johnson D. C. 1987; Cyclosporin A inhibits herpes simplex virus-induced cell fusion but not virus penetration into cells. Virology 159:1–9
    [Google Scholar]
13. Mousli M., Bueb J.-L., Bronner C., Rouot B., Landry Y. 1990; G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends in Biochemical Sciences 11:358–362
    [Google Scholar]
14. Nicchitta C. V., Kamoun M., Williamson J. R. 1985; Cyclosporin augments receptor-mediated cellular Ca⁺⁺ fluxes in isolated hepatocytes. Journal of Biological Chemistry 260:13613–13618
    [Google Scholar]
15. Pogue-Geile K. L., Spear P. G. 1987; The single base pair substitution responsible for the syn phenotype of herpes simplex virus type 1, strain MP. Virology 157:67–74
    [Google Scholar]
16. Pogue-Geile K. L., Lee G. T. Y., Shapiro S. K., Spear P. G. 1984; Fine mapping of mutations in the fusion-inducing MP strain of herpes simplex virus type 1. Virology 136:100–109
    [Google Scholar]
17. Roos D. S., Duchala C. S., Stephenson C. B., Holmes K. V., Choppin P. W. 1990; Control of virus-induced cell fusion by host lipid composition. Virology 175:345–357
    [Google Scholar]
18. Ruyechan W. T., Morse L. S., Knipe D. M., Roizman B. 1979; Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells. Journal of Virology 29:677–697
    [Google Scholar]
19. Sanders P. G., Wilkie N. M., Davison A. J. 1982; Thymidine kinase deletion mutants of herpes simplex virus type 1. Journal of General Virology 63:277–295
    [Google Scholar]
20. Spear P. 1987; Virus-induced cell fusion. In Cell Fusion pp 3–32 Edited by Sowers A. E. New York: Plenum Press;
    [Google Scholar]
21. Tognon M., Manservigi R., Romanelli M. G., Rotola A., Gatti R., Foà-Tomasi L., Campadelli-Fiume G. 1988; A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpes-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncytial mutation. Archives of Virology 98:199–212
    [Google Scholar]
22. Walev I., Wollert K. C., Weise K., Falke D. 1991; Characterization of fusion from without induced by herpes simplex virus. Archives of Virology 117:29–44
    [Google Scholar]
23. Weise K., Kaerner H. C., Glorioso J., Schrӧder C. H. 1987; Replacement of glycoprotein B gene sequences in herpes simplex virus type 1 strain ANG by corresponding sequences of the strain KOS causes changes in plaque morphology and neuropathogenicity. Journal of General Virology 68:1909–1919
    [Google Scholar]
24. Weizhong C., Gu B., Person S. 1988; Role of glycoprotein B of herpes simplex type 1 in viral entry and cell fusion. Journal of Virology 62:2596–2604
    [Google Scholar]
25. Wenger R. 1986; Cyclosporin and analogues: structural requirements for immunosuppressive activity. Transplantation Proceedings 18: supplement 5213–218
    [Google Scholar]